Merck MRK
NYSE MRK
$146.77 -0.36 (-0.24%)
At close: Sep 18, 2026 · 4:00 PM EDT

Merck (MRK) Preferred Dividend Payments (2009)

Merck's (MRK) quarterly Preferred Dividend Payments came in at -$110.9 million in Q4 2009, down 391.84% quarter-over-quarter from $38.0 million in Q3 2009.

Analysis

Merck (MRK) Preferred Dividend Payments (2009) Analysis & Trends

Merck (MRK) has reported Preferred Dividend Payments for 1 consecutive years, with -$110.9 million the latest figure, recorded in Q4 2009.

  • On a quarterly basis, Preferred Dividend Payments changed N/A year-over-year to -$110.9 million in Q4 2009; TTM through Dec 2009 was -$147.9 million, a N/A change from a year earlier, with the FY2009 full-year figure at $2.1 million, changed N/A from the prior year.
  • Preferred Dividend Payments was -$110.9 million for Q4 2009 at Merck, down from $38.0 million in the prior quarter.
  • Over five years, Preferred Dividend Payments peaked at $38.0 million in Q2 2009 and troughed at -$110.9 million in Q4 2009.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Pref Dividends (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn -
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn -
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn -
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn -
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn -
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn -
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn -
8 Revolution Medicines 40.91 Bn 40.91 Bn - -
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn -
10 Incyte 25.18 Bn 20.65 Bn 1.57 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2009 -110.90 Mn
Sep 30, 2009 38.00 Mn
Jun 30, 2009 38.00 Mn